# EDGAR Filing Document

**Accession Number:** 0001538495
**File Stem:** 0001493152-26-028050
**Filing Date:** 2026-6
**Character Count:** 12796
**Document Hash:** 49c276380a11c64bb7a19446cce3812a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-028050.hdr.sgml**: 20260610

**ACCESSION NUMBER**: 0001493152-26-028050

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260610

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260610

**DATE AS OF CHANGE**: 20260610

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Earth Science Tech, Inc.
- **CENTRAL INDEX KEY:** 0001538495
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 454267181
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55000
- **FILM NUMBER:** 261078303

**BUSINESS ADDRESS:**
- **STREET 1:** 8950 SW 74TH CT
- **STREET 2:** SUITE 101
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33156
- **BUSINESS PHONE:** (786) 375-7281

**MAIL ADDRESS:**
- **STREET 1:** 8950 SW 74TH CT
- **STREET 2:** SUITE 101
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33156

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ultimate Novelty Sports Inc.
- **DATE OF NAME CHANGE:** 20111230

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **June 10, 2026**

Commission File No. 000-55000

**<u>EARTH SCIENCE TECH, INC.</u>**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **florida** | **45-4267181** |
| (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | Identification No.) |

---

**<u>8950 SW 74<sup>th</sup> CT</u>**

**<u>Suite 1401</u>**

**<u>Miami, FL 33156, USA</u>**

(Address of principal executive offices, zip code)

**<u>(305) 724-5684</u>**

(Registrant's telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(g) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Stock $0.001 par value | ETST | Over the Counter Bulletin Board |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 7.01 Regulation FD Disclosure**

On June 10, 2026, the Company issued a press release (the "Release") announcing its annual shareholder letter for FY ended March 31, 2026.

A copy of the Release issued by the Company on June 10, 2026, is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

**Item 9.01. Financial Statements and Exhibits.**

(d) *Exhibits* – The following exhibits are filed as part of this report:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | [Press release issued by the registrant on June 10, 2026](ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **EARTH SCIENCE TECH, INC.** | **EARTH SCIENCE TECH, INC.** |
| **Dated: June 10, 2026** | **By:** | ***/s/ Giorgio R. Saumat*** |
|  |  | Giorgio R. Saumat |
|  | **Its:** | **CEO and Chairman of the Board** |

---

## Exhibit 99.1

**Exhibit 99.1**

**Earth Science Tech, Inc. (ETST) Annual Shareholder Letter for FY Ended March 31, 2026**

 

*"We measure our progress not only by the milestones we reached, but by the capabilities we built to reach the ones still ahead."*

● Over 6.9 million shares of common stock repurchased since fiscal Q1 2026

● Peaks Curative surpassed $2 million in revenue in the first week of Fiscal Q4 2026

● Cash flow positive across its operating platform

● Expanding with disciplined, debt-free growth

Miami, FL, June 10, 2026, Earth Science Tech, Inc. (OTC: ETST) ("ETST" or "Company"), a strategic holding company, today provided a business update in a letter to shareholders.

Dear Shareholders,

The fiscal year ended March 31, 2026, was a truly transformational one for our company. It was not an easy year—we navigated real highs and lows—but I believe we set the stage for the next leg of our journey: the chapter in which Earth Science Tech turns from a bold endeavor into a lasting legacy, one this management team will be proud to have built. And for those who don't yet know who ETST is, I'll say it plainly—I believe you are going to be sorry you weren't paying attention.

To make that case, let me share a few of the milestones we reached last fiscal year. As you read them, I'd ask you to notice the theme that runs through every one:

● Having acquired the Texas property that houses Mister Meds in the prior fiscal year, we built the location from the ground up and launched operations that grow stronger every day—without adding any debt to our balance sheet.

● Having acquired DOConsultation and Villas Health, we turned both assets around, and together they are now cash flow positive. Their impact has reached across our entire health/wellness segment, and they were instrumental in the achievement that follows in the next bullet point—without adding any debt to our balance sheet.

● We redesigned and rebuilt our proprietary technology stack and re-launched MyOnlineConsultation (MOC Teledoc) as a prescriber network that has been cash flow positive since its very first day of operation—without adding any debt to our balance sheet.

● We accelerated our marketing efforts at Peaks and grew their revenue substantially, surpassing the $2 million mark in the first week of our fourth quarter—without adding any debt to our balance sheet.

● We permitted and built out the first residential property at Avenvi, which is under contract for sale—without adding any debt to our balance sheet.

● We repurchased and retired 3,773,296 shares of our outstanding stock—without adding any debt to our balance sheet.

● And after a long and costly process, FINRA cleared our Form 211 in December—funded, once again, without adding any debt to our balance sheet.

I could go on, but I want to keep this letter brief, and we will be filing our 10-K annual report in the coming weeks. The point is simply this: in my view, we began the new fiscal year in a position of real financial strength.

Looking ahead, our core focus remains on optimizing the operational frameworks of our holdings to support scalable, sustainable expansion. For the sake of clarity, transparency, and financial alignment, effective March 31, 2026 (Fiscal Year 2026) we will present our results across two primary segments: Health/Wellness and Corporate/Other. When we file our 10-K, you will also notice that we have refined our description of the company to better reflect what Earth Science Tech does as a consolidated entity. I expect every company under the ETST umbrella to expand its geographic footprint this year, and we will pursue acquisitions and/or partnerships where they help us meet that goal.

Our Health/Wellness segment is the core operating engine of the company, and we expect it to drive most of the total revenue this fiscal year. It is building genuine forward momentum, fueled by rising volumes, expanding provider relationships, and the advantages of a vertically integrated model.

Our Corporate/Other segment has generated strong cash flow quarter-to-date. Currently, the company has three additional properties for development awaiting final permit approval. We have also retired 3,150,392 shares of our common stock quarter-to-date.

On behalf of the entire leadership team, I extend my sincere gratitude to you, our shareholders, for your continued trust and support. Everything we have achieved is the direct result of collective dedication—and it marks the beginning of what we believe is a far larger corporate trajectory.

I cannot end this letter without stating, as the largest shareholder of ETST, how proud I am of all the people that work at ETST and/or its holdings. We have the best management team I have ever been a part of and the culture that filters down through the entire organization is nothing short of amazing.

I look forward to meeting shareholders at the Planet Microcap Conference in Las Vegas on June 16<sup>th</sup> – 18<sup>th</sup> or at our annual shareholder meeting (date TBD – after we file our 10-K annual report).

As we set our sights on the milestones ahead, we remain fiercely committed to transparency and to a relentless focus on maximizing shareholder value.

Regards,

**Giorgio R. Saumat**

CEO & Chairman of the Board

**About Earth Science Tech, Inc. (ETST)** 

Earth Science Tech, Inc. operates as a diversified holding company focused on the health and wellness sector. The Company's principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The Company's healthcare operations are supported by investments in real estate and asset management activities and a consumer products business.

The core of the Company's value proposition is the seamless integration of patient care, from consultation to fulfillment. This is achieved through the synergy of specialized subsidiaries.

To learn more, please visit: <u>www.ETST.com</u>

**Forward-Looking Statements**

Except for historical information, the matters discussed herein may be considered "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as "expect," "expectation," "believe," "anticipate," "may," "could," "intend," "belief," "plan," "estimate," "target," "predict," "likely," "seek," "project," "model," "ongoing," "will," "should," "forecast," "outlook" or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company's actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company's products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.

**Contact:**

Hayden IR

James Carbonara

(646)-755-7412

<u>james@haydenir.com</u>

Brett Maas

(646) 536-7331

<u>brett@haydenir.com</u>